These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28248265)

  • 1. Partial-Body Irradiation in Patients with Prostate Cancer Treated with IMRT Has Little Effect on the Composition of Serum Proteome.
    Pietrowska M; Jelonek K; Polanska J; Wojakowska A; Marczak L; Chawinska E; Chmura A; Majewski W; Miszczyk L; Widlak P
    Proteomes; 2015 Jun; 3(3):117-131. PubMed ID: 28248265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy--A Pilot Study.
    Widlak P; Jelonek K; Wojakowska A; Pietrowska M; Polanska J; Marczak Ł; Miszczyk L; Składowski K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1108-1115. PubMed ID: 26031365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue.
    Widłak P; Pietrowska M; Polańska J; Rutkowski T; Jelonek K; Kalinowska-Herok M; Gdowicz-Kłosok A; Wygoda A; Tarnawski R; Składowski K
    J Transl Med; 2013 Dec; 11():299. PubMed ID: 24304975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
    Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
    J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-related changes in serum proteome profiles detected by mass spectrometry in blood of patients treated with radiotherapy due to larynx cancer.
    Widłak P; Pietrowska M; Wojtkiewicz K; Rutkowski T; Wygoda A; Marczak L; Marczyk M; Polańska J; Walaszczyk A; Domińczyk I; Składowski K; Stobiecki M; Polański A
    J Radiat Res; 2011; 52(5):575-81. PubMed ID: 21768750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced changes in serum lipidome of head and neck cancer patients.
    Jelonek K; Pietrowska M; Ros M; Zagdanski A; Suchwalko A; Polanska J; Marczyk M; Rutkowski T; Skladowski K; Clench MR; Widlak P
    Int J Mol Sci; 2014 Apr; 15(4):6609-24. PubMed ID: 24747595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer.
    Teh BS; Mai WY; Augspurger ME; Uhl BM; McGary J; Dong L; Grant WH; Lu HH; Woo SY; Carpenter LS; Chiu JK; Butler EB
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):465-72. PubMed ID: 11173142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.
    Teh BS; Mai WY; Uhl BM; Augspurger ME; Grant WH; Lu HH; Woo SY; Carpenter LS; Chiu JK; Butler EB
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):705-12. PubMed ID: 11172952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of treatment volumes and techniques in prostate cancer radiation therapy.
    Lee CT; Dong L; Ahamad AW; Choi H; Cheung R; Lee AK; Horne DF; Breaux AJ; Kuban DA
    Am J Clin Oncol; 2005 Dec; 28(6):618-25. PubMed ID: 16317275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of serum proteome homeostasis during radiation therapy by a quantitative proteomics approach.
    Ouerhani A; Chiappetta G; Souiai O; Mahjoubi H; Vinh J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31300526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity.
    Jelonek K; Pietrowska M; Widlak P
    Int J Radiat Biol; 2017 Jul; 93(7):683-696. PubMed ID: 28281355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer.
    Spratt DE; Zumsteg ZS; Ghadjar P; Kollmeier MA; Pei X; Cohen G; Polkinghorn W; Yamada Y; Zelefsky MJ
    BJU Int; 2014 Sep; 114(3):360-7. PubMed ID: 24447404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of dose-volume profiles and its implication for radiation therapy planning in prostate carcinoma.
    Vanasek J; Odrazka K; Dolezel M; Kolarova I; Jarkovsky J; Pavlik T; Hlavka A; Dusek L
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):769-76. PubMed ID: 23628133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
    Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.
    Nasser NJ; Thoms J; Soosaipillai A; Pintilie M; Wang R; Diamandis EP; Bristow RG
    Radiother Oncol; 2017 Sep; 124(3):427-432. PubMed ID: 28427756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizing radiation affects the composition of the proteome of extracellular vesicles released by head-and-neck cancer cells in vitro.
    Abramowicz A; Wojakowska A; Marczak L; Lysek-Gladysinska M; Smolarz M; Story MD; Polanska J; Widlak P; Pietrowska M
    J Radiat Res; 2019 May; 60(3):289-297. PubMed ID: 30805606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.